Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis.

Saved in:

Bibliographic Details
Title:	Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis.
Authors:	Koop K; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Enderle K; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Hillmann M; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Ruspeckhofer L; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Vieth M; Institute of Pathology, Klinikum Bayreuth, Friedrich-Alexander-Universität Erlangen-Nürnberg, Bayreuth, Germany., Sturm G; Biocenter, Institute of Bioinformatics, Medical University Innsbruck, Innsbruck, Austria., Trajanoski Z; Biocenter, Institute of Bioinformatics, Medical University Innsbruck, Innsbruck, Austria.; The Transregio 241 IBDome Consortium, Erlangen, Germany., Kühl AA; The Transregio 241 IBDome Consortium, Erlangen, Germany.; iPATH.Berlin, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Atreya R; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; The Transregio 241 IBDome Consortium, Erlangen, Germany., Leppkes M; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Baum P; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany., Roy J; Staburo GmbH, München, Germany., Martin A; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United States., Neurath MF; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Deutsches Zentrum Immuntherapie, Erlangen, Germany., Neufert C; First Department of Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Deutsches Zentrum Immuntherapie, Erlangen, Germany.
Source:	Frontiers in immunology [Front Immunol] 2023 May 03; Vol. 14, pp. 1163198. Date of Electronic Publication: 2023 May 03 (Print Publication: 2023).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2023.1163198